TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo.
about
TRPV1 Channel: A Potential Drug Target for Treating EpilepsyCannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disordersInterference of TRPV1 function altered the susceptibility of PTZ-induced seizuresSeizure reduction through interneuron-mediated entrainment using low frequency optical stimulation.Molecular Targets of Cannabidiol in Neurological DisordersThe potential role of cannabinoids in epilepsy treatment.Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain.Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.The Transient Receptor Potential Vanilloid 1 Antagonist Capsazepine Improves the Impaired Lung Mechanics during Endotoxemia.Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice.α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice.Effects of TRPV1 on the hippocampal synaptic plasticity in the epileptic rat brain.Antinociceptive effect of natural and synthetic alkamides involves TRPV1 receptors.Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model.Characteristics of sensory neuronal groups in CGRP-cre-ER reporter mice: Comparison to Nav1.8-cre, TRPV1-cre and TRPV1-GFP mouse lines.The Endocannabinoid System and Oligodendrocytes in Health and Disease
P2860
Q26786478-BC3D02C6-1500-4F89-BD1B-C59A17B51068Q26823267-1F75DFB9-52F1-46EE-A733-5D1F6933356FQ35067058-9E5C062E-846D-41CD-B0BA-0DA68E885168Q35655896-FEA78775-47CE-42F6-9FE1-1A1893B321F2Q36157649-970D5AFD-16E9-4CAF-AA46-7429D26FC306Q38606080-481B0197-7D1B-449E-B565-EBC239331C42Q38840483-72FD121E-04F9-4AA2-98A2-EDA8A8CB4143Q39038882-74F97562-37F1-4620-983D-DA4BB915A975Q40709500-60172C09-5D15-4591-838A-75664ED6A525Q41117634-03075CC1-BD1D-4015-8C4F-0AD33D215C7DQ42046872-21112F43-A097-4942-ACEC-6B66FFEF8256Q48181009-A0B72788-5FAB-4390-A135-D7A72DD962C5Q48325171-F34BC282-0424-4470-B65E-6E937DC8DB8DQ51735358-FA8C8633-FB99-4532-8567-417F5B9BA777Q55101254-AB363BC3-8A0A-4543-AD6E-09C1C2BBA430Q58707257-1566A344-46CA-4129-B590-1CFA5099C268
P2860
TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@en
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@nl
type
label
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@en
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@nl
prefLabel
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@en
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@nl
P2093
P2860
P1476
TRPV1 antagonist capsazepine s ...... ectrographic seizures in vivo.
@en
P2093
Chia-Chu Chiang
Luis E Gonzalez-Reyes
Thomas P Ladas
P2860
P304
P356
10.1016/J.EXPNEUROL.2013.10.010
P407
P577
2013-10-18T00:00:00Z